Overview and Diagnostic Definition
The Pediatric Acute Lung Injury Consensus Conference-2 (PALICC-2, published 2023) updated the 2015 diagnostic and management criteria for Pediatric Acute Respiratory Distress Syndrome (PARDS). PALICC-2 harmonizes non-invasive respiratory modalities, establishes objective definitions for non-intubated children, and refines severity stratifications.
PALICC-2 Core Diagnostic Criteria
- Timing: Acute onset within 7 days of a known clinical insult (sepsis, severe pneumonia, aspiration, trauma, pancreatitis, transfusion).
- Origin of Edema: Respiratory failure not fully explained by left ventricular heart failure or fluid overload (confirmed clinically or via echocardiography).
- Radiographic Findings: New bilateral pulmonary infiltrates/opacities on chest radiography (CXR) or computed tomography (CT) consistent with acute pulmonary parenchymal disease.
- Alternative in Resource-Limited Settings (RLS): Chest ultrasound showing bilateral B-lines or consolidation can be utilized if CXR/CT is unavailable.
- Oxygenation Defect: Stratified by mode of respiratory support (Invasive Mechanical Ventilation vs Non-Invasive Respiratory Support).
Severity Stratification
1. Invasively Ventilated PARDS
Assessed after a minimum stabilization period of 4 hours on mechanical ventilation, utilizing arterial blood gas measurements or pulse oximetry:
$$\text{Oxygenation Index (OI)} = \frac{\text{Mean Airway Pressure (MAP in cmH}_2\text{O)} \times \text{FiO}_2 \times 100}{\text{PaO}_2\text{ (in mmHg)}}$$$$\text{Oxygen Saturation Index (OSI)} = \frac{\text{Mean Airway Pressure (MAP in cmH}_2\text{O)} \times \text{FiO}_2 \times 100}{\text{SpO}_2\text{ (when }\text{SpO}_2 \le 97\%)}$$| Severity Tier | Invasive OI Criteria (Arterial ABG) | Invasive OSI Criteria (Pulse Oximetry) |
|---|---|---|
| Mild PARDS | $4 \le \text{OI} < 8$ | $5 \le \text{OSI} < 7.5$ |
| Moderate PARDS | $8 \le \text{OI} < 16$ | $7.5 \le \text{OSI} < 12.3$ |
| Severe PARDS | $\text{OI} \ge 16$ | $\text{OSI} \ge 12.3$ |
2. Non-Invasive PARDS (BiPAP / CPAP)
Applied in children on full-face mask or nasal mask CPAP or BiPAP with continuous positive airway pressure $\ge 5\text{ cmH}_2\text{O}$:
- Criteria: $\text{PaO}_2 / \text{FiO}_2 \le 300\text{ mmHg}$ OR $\text{SpO}_2 / \text{FiO}_2 \le 264$ (with $\text{SpO}_2 \le 97\%$).
3. "Possible PARDS" (Novel PALICC-2 Category)
Identifies children on high-flow nasal oxygen before intubation to prompt early lung-protective care and monitoring:
- Oxygen Modality: High-Flow Nasal Cannula (HFNC) at flow rates:
- Age $<1\text{ year}$: Flow $\ge 1.5\text{ L/kg/min}$
- Age $\ge 1\text{ year}$: Flow $\ge 2.0\text{ L/kg/min}$ (or total flow $>30\text{ L/min}$)
- Oxygenation Threshold: $\text{SpO}_2 / \text{FiO}_2 \le 264$ (with $\text{SpO}_2 \le 97\%$).
- Radiology: Bilateral infiltrates on imaging.
flowchart TD
A["Acute Respiratory Deterioration (< 7 days) + Bilateral Infiltrates"] --> B{"Current Respiratory Support?"}
B -->|"HFNC (≥ 1.5–2 L/kg/min)"| C{"SpO2 / FiO2 ≤ 264?"}
C -->|Yes| D["Possible PARDS<br/>(Monitor ROX, avoid delayed intubation)"]
C -->|No| E["Acute Hypoxemic Failure (Not PARDS)"]
B -->|"CPAP / BiPAP (PEEP ≥ 5 cmH2O)"| F{"PaO2/FiO2 ≤ 300 OR SpO2/FiO2 ≤ 264?"}
F -->|Yes| G["Non-Invasive PARDS"]
B -->|"Invasive Mechanical Ventilation"| H["Calculate OI or OSI (post 4h)"]
H -->|"OI 4–7.9 OR OSI 5–7.4"| I["Mild PARDS"]
H -->|"OI 8–15.9 OR OSI 7.5–12.2"| J["Moderate PARDS"]
H -->|"OI ≥ 16 OR OSI ≥ 12.3"| K["Severe PARDS"]
Lung-Protective Mechanical Ventilation Protocol
PALICC-2 mandates physiologic lung protection to prevent Ventilator-Induced Lung Injury (VILI):
| Ventilatory Parameter | Target / Guideline | Clinical Rationale & Evidence |
|---|---|---|
| Tidal Volume ($V_T$) | $4–8\text{ mL/kg}$ (Predicted Body Weight) | $3–6\text{ mL/kg}$ for severely non-compliant lungs; $6–8\text{ mL/kg}$ for preserved compliance. Avoids volutrauma. |
| Inspiratory Plateau Pressure ($P_{\text{plat}}$) | $\le 28\text{ cmH}_2\text{O}$ (up to $30\text{ cmH}_2\text{O}$ if chest wall compliance is reduced) | Prevents alveolar overdistension and barotrauma. |
| Driving Pressure ($\Delta P = P_{\text{plat}} - \text{PEEP}$) | $< 15\text{ cmH}_2\text{O}$ | Strongest independent ventilator predictor of mortality in adult and pediatric ARDS cohorts. |
| PEEP Titration | Titrate according to pediatric high-PEEP / FiO2 titration matrices ($10–15\text{ cmH}_2\text{O}$ in severe disease) | Maintains functional residual capacity (FRC) and prevents cyclic alveolar collapse (atelectotrauma). |
| Gas Exchange Targets | Permissive Hypercapnia: Target $\text{pH } 7.20–7.35$; $\text{PaCO}_2$ allowable up to $55–70\text{ mmHg}$ | Minimizes mandatory minute ventilation demands. Absolute contraindication: elevated intracranial pressure or severe pulmonary hypertension. |
| Oxygenation Goals | $\text{SpO}_2\ 92–97\%$ if $\text{PEEP} < 10$; permissive hypoxemia $\text{SpO}_2\ 88–92\%$ if $\text{PEEP} \ge 10\text{ cmH}_2\text{O}$ | Avoids oxygen toxicity and free-radical pulmonary capillary endothelial damage. |
Ancillary and Rescue Management
flowchart TD
A["Invasive PARDS Confirmed"] --> B["Apply Lung-Protective Ventilation<br/>(Vt 4–8 mL/kg, Pplat ≤ 28, ΔP < 15, High PEEP)"]
B --> C{"Severity Assessment"}
C -->|"Mild (OI 4–8)"| D["Conservative Fluid Management<br/>Sedation titration"]
C -->|"Moderate (OI 8–16)"| E["Prone Positioning (≥ 16 h/day)<br/>Early Neuromuscular Blockade (24–48 h)"]
C -->|"Severe (OI ≥ 16)"| F["Prone Positioning + Deep Paralysis<br/>Trial Inhaled Nitric Oxide (iNO 10–20 ppm)"]
F --> G{"Refractory Hypoxemia<br/>(OI > 40 or pH < 7.15 despite optimization)?"}
G -->|Yes| H["HFOV Rescue Ventilation<br/>OR Veno-Venous (VV) ECMO Referral"]
G -->|No| I["Continue Lung-Protective De-escalation"]
1. Prone Positioning
- Indication: Moderate-to-severe PARDS ($\text{OI} \ge 8$ or $\text{OSI} \ge 7.5$).
- Duration: Minimum continuous $\ge 16\text{ hours/day}$.
- Mechanism: Improves dorsal alveolar recruitment, optimizes ventilation-perfusion ($V/Q$) matching, reduces transpulmonary pressure gradients, and facilitates dependent secretion drainage.
- Evidence: PROSEVA trial (adults) demonstrated clear 28-day mortality benefit (16% vs 32%); pediatric prospective cohorts confirm sustained improvement in OI and extubation success.
2. Neuromuscular Blockade (NMB)
- Agent: Cisatracurium or vecuronium infusion for 24 to 48 hours.
- Indications: Severe PARDS, patient-ventilator dyssynchrony, elevated transpulmonary driving pressures, or refractory hypoxemia.
- Caveat: Titrate with Train-of-Four (TOF) monitoring; avoid prolonged courses $>48\text{ hours}$ to prevent critical illness myopathy.
3. Inhaled Nitric Oxide (iNO)
- Role: Selective pulmonary vasodilator (10–20 ppm).
- PALICC-2 Position: Not routinely recommended for all PARDS cases. Reserved as rescue therapy for:
- Documented pulmonary hypertension or acute cor pulmonale.
- Refractory hypoxemia as a bridge to ECMO.
- If no oxygenation response within 4 hours, iNO must be discontinued.
4. Fluid Stewardship
- Conservative fluid strategy post-initial resuscitation (e.g., target cumulative net-zero or negative fluid balance by Day 3–5).
- Fluid overload $>10–15\%$ body weight correlates directly with prolonged mechanical ventilation days, secondary PICU infections, and increased mortality.
5. Advanced Rescue: HFOV and ECMO
- High-Frequency Oscillatory Ventilation (HFOV): Rescue mode for severe air leaks or refractory hypercapnic/hypoxemic failure where conventional protective targets fail.
- Extracorporeal Membrane Oxygenation (ECMO):
- Modality: Veno-Venous (VV) ECMO for isolated respiratory failure; Veno-Arterial (VA) ECMO if concomitant myocardial failure or septic cardiomyopathy.
- Trigger Criteria: Refractory hypoxemic failure with $\text{OI} > 40$ or uncompensated hypercapnic acidosis ($\text{pH} < 7.15$) despite prone positioning and maximal protective ventilation.
Comparison: Berlin Definition vs PALICC-1 vs PALICC-2
| Feature | Berlin Definition (2012, Adult) | PALICC-1 (2015) | PALICC-2 (2023) |
|---|---|---|---|
| Age Exclusion | Excludes neonates | Excludes neonates with cyanotic CHD or RDS | Harmonized across pediatrics (post-neonatal through 18 yr) |
| Non-Invasive Diagnostic Role | CPAP $\ge 5\text{ cmH}_2\text{O}$ (Mild ARDS only) | CPAP / BiPAP with full mask | CPAP / BiPAP + HFNC defined ("Possible PARDS") |
| Primary Metric | $\text{PaO}_2 / \text{FiO}_2$ ratio only | OI primary, OSI secondary | OI and OSI fully co-validated with specific cutoff tiers |
| High-Flow Cannula | Excluded | Not formally defined | Included with specific flow thresholds ($\ge 1.5–2\text{ L/kg/min}$) |
| Prone Positioning | Recommended in severe ARDS | Suggested | Strongly recommended $\ge 16\text{ h/day}$ in moderate-severe |
| Driving Pressure | Not specified in criteria | Acknowledged | Formal target: $\Delta P < 15\text{ cmH}_2\text{O}$ |
| Resource-Limited Settings (RLS) | No criteria | Clinical guidance only | Ultrasound-based criteria & pulse-oximetry formulas |